News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. administration plans to lift export restrictions on Anthropic's Fable 5, allowing broader user access and easing AI export controls.
  • Microsoft plans job cuts next week affecting thousands across sales, consulting and Xbox as it shifts spending toward AI.
  • Oaktree-backed ITG priced its IPO at $16 a share, below range, raising $312.2 million for Nasdaq listing.
  • Brazil warns fiscal targets will be unattainable from 2028 without new revenues or cuts as mandatory spending outpaces growth.
  • U.S. Education and Justice Departments pursue enforcement, including possible funding cuts, against Kansas City schools over transgender privacy policy.
  • Ukraine's commander warns forces are preparing for a potential Russian offensive from the north, risking wider strain on Ukrainian defenses.

Latest Articles

Why Travere's Filspari Approval Odds Look Underpriced at $31.59

Why Travere's Filspari Approval Odds Look Underpriced at $31.59

Travere Therapeutics (TVTX) is trading in a tight range around $31.59 with low-to-moderate volume. Market pricing appears to understate the value of a potential Filspari approval for FSGS. This trade targets a material re-rating on positive regulatory news while keeping a disciplined stop to limit downside if the binary outcome goes the other way.

U.S. Life Expectancy Reaches Record 79 Years in 2024, CDC Says

U.S. Life Expectancy Reaches Record 79 Years in 2024, CDC Says

The U.S. life expectancy rose to 79.0 years in 2024, marking an increase of more than six months from 2023 and setting a new high, according to a report released by the Centers for Disease Control and Prevention's National Center for Health Statistics. The gain reflects notable decreases in deaths from COVID-19 and certain unintentional injuries, a…

Copenhagen shares slide as tech, healthcare and chemicals lead losses

Copenhagen shares slide as tech, healthcare and chemicals lead losses

Denmark's benchmark OMX Copenhagen 20 closed lower on Thursday, slipping 1.24% as declines in the Technology, Healthcare and Chemicals sectors weighed on the market. AP Moeller - Maersk's share classes and Coloplast were among the session's gainers, while Novo Nordisk, Oersted and Jyske Bank posted notable declines. Commodity prices moved sharply, …

Evercore Keeps IBM at Outperform, Removes Tactical Call After Strong Q4

Evercore Keeps IBM at Outperform, Removes Tactical Call After Strong Q4

Evercore ISI maintained an Outperform rating on IBM with a $345 price target but removed the stock from its Tactical Outperform list after the company posted stronger-than-expected fourth-quarter results. IBM beat revenue and EPS estimates, recorded broad-based segment growth, and issued 2026 guidance above Street expectations for sales and free ca…

UBS Keeps Buy Rating on Microsoft Citing Capacity and Backlog Dynamics

UBS Keeps Buy Rating on Microsoft Citing Capacity and Backlog Dynamics

UBS reiterated a Buy rating and a $600 price target on Microsoft after the company's latest earnings release, pointing to a favorable capacity outlook and potential backlog conversion. Microsoft reported double-digit revenue and EPS growth, while Azure and Microsoft 365 growth rates landed just below UBS estimates. Multiple other brokerages adjuste…

UBS Sticks with Buy on AT&T, Keeps $31 Target After Strong Q4 Results

UBS Sticks with Buy on AT&T, Keeps $31 Target After Strong Q4 Results

UBS has reaffirmed a Buy rating on AT&T and held its $31.00 price target after the carrier reported stronger-than-expected fourth-quarter results. The firm described the quarter as solid and said AT&T’s expansive fiber footprint and convergence advantages point to accelerating profit growth and rising free cash flow. Other analysts offered mixed re…

BRB Faces Potential Near-1 Billion Dollar Hit Tied to Banco Master Transactions

BRB Faces Potential Near-1 Billion Dollar Hit Tied to Banco Master Transactions

A central bank official told investigators that state-run Banco de Brasília (BRB) may need to allocate in excess of 5 billion reais to cover dealings with failed lender Banco Master. The estimate is significantly higher than an earlier provision and follows probes into large transfers and questions over the nature of assets involved in the transact…

UBS Lifts Meta Platforms Price Target to $872, Cites AI Revenue Tailwinds

UBS Lifts Meta Platforms Price Target to $872, Cites AI Revenue Tailwinds

UBS raised its price target on Meta Platforms to $872 from $830 and kept a Buy rating, citing guidance for 2026 operating and capital spending and the company’s expected realization of AI-driven revenue streams. The firm highlighted substantial ad monetization dollar growth and strong margin and revenue trends, while other brokerages also adjusted …

C.H. Robinson Shares Jump After Strong Q4 Results and Analyst Backing

C.H. Robinson Shares Jump After Strong Q4 Results and Analyst Backing

C.H. Robinson’s shares rose sharply in after-hours trade following a fourth-quarter earnings beat, Benchmark’s reaffirmation of a Buy rating with a $160 target, and a string of upward price-target revisions from other brokerages. The freight broker reported modest EPS growth, margin gains across key segments and continued market-share momentum desp…

UBS Lifts GE Vernova Price Target to $936, Cites Strong Margin Trajectory

UBS Lifts GE Vernova Price Target to $936, Cites Strong Margin Trajectory

UBS raised its price target on GE Vernova to $936 from $835 while retaining a Buy rating after the company's fourth-quarter results and margin disclosures. UBS said it has increased conviction that margins can materially surpass medium-term targets and consensus, pointing to equipment backlog margin contribution and future pricing in service agreem…

C.H. Robinson Posts Quarterly Surprise as UBS Sticks With Buy Rating

C.H. Robinson Posts Quarterly Surprise as UBS Sticks With Buy Rating

C.H. Robinson reported adjusted fourth-quarter EPS of $1.23, beating the $1.13 consensus. UBS maintained a Buy rating with a $224 price target, citing an earnings surprise and stronger-than-expected cost discipline. Several other brokerages raised price targets after the print as the company showed market share gains, margin improvements and operat…

Public Policy Holding Chief Strategy Officer Disposes $30,429 in Shares

Public Policy Holding Chief Strategy Officer Disposes $30,429 in Shares

Thomas Edward Gensemer, Chief Strategy Officer at Public Policy Holding Company (NASDAQ:PPHC), sold 2,484 shares on January 27, 2026 for $12.25 each, netting $30,429. The sale occurred as PPHC shares have dropped more than 15% over the prior week and trade at $12.00. InvestingPro analysis describes the stock as appearing undervalued versus its Fair…